WM
67
14
UNH
32
10
HUM
40
9
PEG
44
5
CINF
43
2
EFX
52
2
NWSA
80
-4
SHW
53
-5
UHS
42
-2
SRE
49
4
SCHW
62
6
WFC
74
3
WYNN
40
-4
XEL
48
2
WHR
50
-5
AFL
48
3
MMM
44
-8
EW
43
2
MOS
53
4
CVX
32
-2
WM
67
14
UNH
32
10
HUM
40
9
PEG
44
5
CINF
43
2
EFX
52
2
NWSA
80
-4
SHW
53
-5
UHS
42
-2
SRE
49
4
SCHW
62
6
WFC
74
3
WYNN
40
-4
XEL
48
2
WHR
50
-5
AFL
48
3
MMM
44
-8
EW
43
2
MOS
53
4
CVX
32
-2
Financhill
Back

Denali Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

DNLI
Denali Therapeutics

Last Price:
$14.00
Seasonality Move:
1.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Denali Therapeutics Stock Forecast

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 13.9% based on the past 7 years of stock performance.
  • Denali Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is Denali Therapeutics Stock Undervalued?
    The current Denali Therapeutics [DNLI] share price is $14.00. The Score for DNLI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Denali Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 13.9% based on the past 7 years of stock performance.

Denali Therapeutics Stock Rating

Sell
23
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics overpriced?

  • Denali Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Denali Therapeutics Stock Price History

Is DNLI stock going to rise?

  • The current trend is moderately bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com

52-Week Data

52-Week High:
33.33
52-Week Low:
10.57

Prediction Charts

Market Cap:
2B
Price in USD:
14.00
Volume:
1.3M
Beta:
1.53

Technical Analysis

SMA50:
14.26
SMA100:
14.56
SMA200:
19.52
52-Wk Change:
-35.72%

Stock Predictions

  • Is Denali Therapeutics stock public?
    Yes, Denali Therapeutics is a publicly traded company.
  • What is the Denali Therapeutics stock quote today?
    The Denali Therapeutics stock price is 14.00 USD today.
  • How to buy Denali Therapeutics stock online?
    You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-30 14.14 13.99 14.55 13.83
Jul-1 14.49 13.95 14.66 13.83
Jul-2 14.06 14.90 15.00 13.94
Jul-3 14.90 14.69 15.00 14.67
Jul-7 14.50 14.25 14.67 14.12
Jul-8 14.30 14.33 14.79 14.24
Jul-9 14.41 15.00 15.16 14.39
Jul-10 15.01 15.35 15.38 14.76
Jul-11 15.05 14.52 15.35 14.38
Jul-14 14.47 14.69 14.98 14.36
Jul-15 14.86 14.17 14.91 14.12
Jul-16 14.41 14.87 14.92 14.33
Jul-17 14.97 14.53 15.15 14.40
Jul-18 14.74 14.00 14.85 13.96

Denali Therapeutics Earnings

Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Denali Therapeutics Forecast Revenue Growth

Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.30 per share, and an increase next year of $0.26 per share.

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.